Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells

16Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aberrant methylation of tumour suppressor genes is associated with the progression to a blast crisis in chronic myeloid leukaemia (CML). Methyl-CpG-binding domain protein 2 (MBD2) has been studied as a “reader” of DNA methylation in many cancers, but its role in CML is unclear. We constructed cell models of a homozygous deletion mutation of MBD2 using gene-editing technology in K562 cells and BV173 cells. Here, we demonstrated that the deletion of MBD2 inhibited cell proliferation capacity in vitro. MBD2 deletion also significantly inhibited K562 cell proliferation in a xenograft tumour model in vivo. Additionally, the JAK2/STAT3 signalling pathway, which is abnormally active in CML, was inhibited by MBD2 deletion, and MBD2 deletion could up-regulate the expression of SHP1. In conclusion, our findings suggest that MBD2 is a candidate therapeutic strategy for the CML blast phase.

References Powered by Scopus

Genome engineering using the CRISPR-Cas9 system

8214Citations
N/AReaders
Get full text

A mouse Mecp2-null mutation causes neurological symptoms that mimic rett syndrome

1290Citations
N/AReaders
Get full text

The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors

476Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1

25Citations
N/AReaders
Get full text

Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy

17Citations
N/AReaders
Get full text

LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation

17Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cheng, L., Tang, Y., Chen, X., Zhao, L., Liu, S., Ma, Y., … Zhou, M. (2018). Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells. Cancer Biology and Therapy, 19(8), 676–686. https://doi.org/10.1080/15384047.2018.1450113

Readers over time

‘18‘19‘20‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

44%

Researcher 3

33%

Professor / Associate Prof. 1

11%

Lecturer / Post doc 1

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

40%

Biochemistry, Genetics and Molecular Bi... 4

40%

Nursing and Health Professions 1

10%

Immunology and Microbiology 1

10%

Save time finding and organizing research with Mendeley

Sign up for free
0